Clinical evaluation of rush immunotherapy using house dust mite allergen in Japanese asthmatics

BACKGROUND: Allergen immunotherapy (AIT) is a specific treatment of administering clinically important allergens to patients who have allergic diseases. In Japan, the standardized house dust mite (HDM) allergen for subcutaneous immunotherapy (SCIT) was approved in 2015, and we then introduced rush-i...

Descripción completa

Detalles Bibliográficos
Autores principales: Uchida, Takahiro, Nakagome, Kazuyuki, Iemura, Hidetoshi, Naito, Erika, Miyauchi, Sachiko, Uchida, Yoshitaka, Soma, Tomoyuki, Nagata, Makoto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asia Pacific Association of Allergy, Asthma and Clinical Immunology 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8331263/
https://www.ncbi.nlm.nih.gov/pubmed/34386408
http://dx.doi.org/10.5415/apallergy.2021.11.e32

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8331263/
https://www.ncbi.nlm.nih.gov/pubmed/34386408
http://dx.doi.org/10.5415/apallergy.2021.11.e32

Ejemplares similares